Results 191 to 200 of about 27,102 (328)

Association Between Metabolic Syndrome, Obesity, and Cognitive Performances in Individuals With Bipolar Disorders: Cross‐Sectional and Longitudinal Analyses in the FACE‐BD Cohort

Acta Psychiatrica Scandinavica, Volume 153, Issue 2, Page 108-121, February 2026.
ABSTRACT Introduction Metabolic syndrome (MetS) has been suggested to be associated with cognitive impairments in bipolar disorder (BD); however, studies are limited by small sample sizes or cross‐sectional design. Our objective is to evaluate the cross‐sectional and longitudinal associations between MetS and cognitive performances in a large cohort of
I. Palimaru, B. Etain, M. Leboyer, Y. Dansou, P. Favre, S. Gard, V. Aubin, F. Bellivier, R. Belzeaux, P. Courtet, C. Dubertret, E. Haffen, A. Lefrere, P. M. Llorca, E. Olié, M. Polosan, L. Samalin, R. Schwan, the FondaMental Academic Centers of Expertise in Bipolar Disorders (FACE‐BD) Collaborators, B. Etain, E. Olié, M. Leboyer, E. Haffen, P. M. Llorca, V. Barteau, S. Bensalem, O. Godin, H. Laouamri, K. Souryis, S. Hotier, A. Pelletier, F. Hergeta, J. Petrucci, L. Willaume, F. Bellivier, B. Etain, V. Hennion, E. Marlinge, J. Meheust, A. Richard, M. Carminati, H. Francisque, S. Gard, K. M’Bailara, C. Elkael, F. Hoorelbeke, I. Minois, J. Sportich, N. Da Ros, C. Dubertret, N. Mazer, C. Portalier, C. Scognamiglio, A. Bing, P. Laurent, L. Boukhobza, P. Courtet, S. Denat, B. Deffinis, D. Ducasse, M. Gachet, A. Lengvenyté, F. Molière, L. Nass, E. Olié, G. Tarquini, A. Lefrere, E. Moreau, J. Pastol, F. Groppi, H. Polomeni, J. Bauberg, L. Lescalier, I. Muraccioli, A. Suray, R. Cohen, J. P. Kahn, M. Milazzo, O. Wajsbrot‐Elgrabli, T. Bougerol, A. Pouchon, A. Bertrand, B. Fredembach, A. Suisse, Q. Denoual, M. Polosan, A. M. Galliot, L. Brehon, G. Bonny, L. Durand, V. Feuga, N. Kayser, P. Roux, V. Aubin, I. Cussac, M. A. Dupont, J. Loftus, I. Medecin, C. Dubertret, N. Mazer, P. Laurent, L. Samalin, P. M. Llorca, M. Mennetrier, T. Bonnet, D. Lacelle, M. Vayssié, C. Beal, O. Blanc, P. Roux, O. Godin   +110 more
wiley   +1 more source

Sleep medication and athletic performance – the evidence for practitioners and future research directions.

Frontiers in Physiology, 2016
Lee eTaylor, Bryna Catherine Rose Chrismas, Ben eDascombe, Karim eChamari, Peter Matthew Fowler   +4 more
doaj   +1 more source

Changing trends in drug overdose mortality in Spain, 2001–2022

Addiction, Volume 121, Issue 2, Page 261-272, February 2026.
Abstract Aim To measure the evolution of drug overdose mortality in Spain between 2001 and 2022. Design, Setting, Participants A repeated cross‐sectional observational study using nationwide mortality data from Spain, 2001–2022, among individuals aged 15–64 years.
Florencia Giné, Marta Donat, Juan Miguel Guerras, Gregorio Barrio, María José Belza, Julieta Politi, Enrique Regidor   +6 more
wiley   +1 more source

Alcohol and other drug treatment services in Australia 2013–14 [PDF]

Alcohol and other drug treatment services across Australia provide a broad range of treatment services and support to people using drugs and to their families and friends. This report presents the information for 2013–14 about publicly funded alcohol and
Australian Institute of Health and Welfare
core   +1 more source

Simultaneous liquid-chromatographic determination of 12 common sedatives and hypnotics in serum.

Clinical Chemistry, 1978
P. Kabra, H. Y. Koo, L. Marton
semanticscholar   +1 more source

Emergency department presentations, hospitalisations and police seizure data related to gamma‐hydroxybutyrate (GHB) in New South Wales, Australia, from 2015 to 2024

Addiction, Volume 121, Issue 2, Page 305-315, February 2026.
Abstract Background and aims Gamma‐hydroxybutyrate (GHB) is an endogenous neurochemical and illicit synthetic drug. Its precursors, gamma‐butyrolactone (GBL) and 1,4‐butanediol (1,4‐BD), are often used as substitutes. We aimed to describe GHB‐related harms in New South Wales (NSW), Australia.
Krista J. Siefried, Janette L. Smith, Christine A. Harvey, Anthony Nedanoski, Jared A. Brown, Una Cullinan, Nadine Ezard, Thanjira Jiranantakan, Darren M. Roberts, Jonathan Brett   +9 more
wiley   +1 more source

Hospitalization linked to antiepileptics, sedative-hypnotics and anti-Parkinsonian drug poisoning, adverse effects, and underdosing in Australia: An ecological study. [PDF]

Medicine (Baltimore)
Naser AY, Alwafi H, Alsharif AA, Al Rajeh AM, Alqahtani JS, Aldhahir AM, Jarab AS, Alhartani YJ, El-Qasem A.   +8 more
europepmc   +1 more source

Pro-active Drug Facilitated Sexual Assault Using Sedative - hypnotic Medication [PDF]

, 2019
Ana Fulga, Anca‐Iulia Neagu, Anamaria Ciubară, Carmina Liana Mușat, Marius Neagu, Iuliu Fulga   +5 more
openalex   +1 more source

Sedatives and hypnotics in Stockholm: social factors and kinds of use.

American Journal of Public Health, 1994
G. Blennow, A. Romelsjö, H. Leifman, A. Leifman, G. Karlsson   +4 more
semanticscholar   +1 more source

Methylphenidate and (lis)dexamfetamine toxicity‐related deaths of adults, Australia, 2000–24: analysis of NCIS data

Medical Journal of Australia, Volume 222, Issue 5, Page 259-261, March 2025.
Shane Darke, Amy Peacock, Johan A Duflou, Michael Farrell, Julia Lappin   +4 more
wiley   +1 more source